119347-95-4Relevant academic research and scientific papers
Method of treatment for prostatic cancer
-
, (2008/06/13)
Disclosed is a new treatment for men with prostatic cancer involving combination therapy of a 5α-reductase inhibitor, i.e., a 17β-substituted 4-azasteroid, a 17β-substituted non-azasteroid, 17β-acyl-3-carboxyandrost-3,5-diene, benzoylaminophenoxybutanoic acid derivative, fused benz(thio)amide or cinnamoylamide derivative, aromatic 1,2-diethers or thioethers, aromatic ortho acylaminophenoxy alkanoic acids, ortho thioalkylacylamino-phenoxy alkanoic acids, pharmaceutically acceptable salts and esters thereof, and particularly finasteride, in combination with an antiandrogen, i.e. flutamide. Pharmaceutical compositions useful for treatment are also disclosed.
BENZOYLAMINOPHENOXYBUTANOIC ACID DERIVATIVES
-
, (2008/06/13)
A benzoylaminophenoxybutanoic acid derivative of general formula: [wherein R 1 represents hydrogen atom or alkyl group of from 1 to 4 carbon atoms(s), A represents oxygen atom, sulfur atom or sulfinyl (SO) group, two R 1 s represents methyl groups or chlo
